AMAZON Pharmacy in the US will automatically apply manufacturer-sponsored coupons to more than 15 insulin and diabetes medicines to help patients access discounts pledged by the drug industry from this week, Reuters has reported.
While coupons for medications are not new, finding and redeeming them isn't always easy.
In fact, an estimated 85% of manufacturer-sponsored coupons go unused, shared Amazon.
With the new program, patients using Amazon Pharmacy may no longer have to search for and manually enter coupons from the three largest insulin makers, Novo Nordisk, Eli Lilly, and Sanofi, to lower the cost of their insulin to as little as US$35 (A$54) for a month's supply, the company said.
Novo, Lilly and Sanofi announced in Mar that they will slash their insulin prices by at least 70% by or in 2024, but a report from US Senator Elizabeth Warren, released last month, said some patients were finding it difficult to get already discounted generic insulin from pharmacies at the promised lower price.
Despite Lilly lowering the list price of its insulin Lispro to US$25 (A$38.75) per vial in May, patients were still being quoted as much as US$330 (A$511) for the medicine, were not being told about cheaper options when they went to pharmacies, and were finding it difficult to use Lilly's savings program, Warren's report found.
Dr Vin Gupta, Amazon Pharmacy's Chief Medical Officer (pictured), said the report highlights the need to make it easier for patients to get their insulin at the lowest possible prices.
"It's not easy to actually figure out how to get that low cost, even though manufacturers and Congress have moved towards that direction.
"Transparency here is really key," he said.
Amazon Pharmacy will also automatically apply available discounts to diabetes-related medical devices from manufacturers Dexcom and Insulet, including continuous glucose monitors and pumps, as well as to other cardiometabolic medicines such as Novo's weight-loss drug Wegovy.
American Diabetes Association Chief Executive Officer Charles Henderson said Amazon's automated discounting will help the 37 million Americans with diabetes more easily access the treatments they need.
"We want those in the diabetes community to be able to make informed decisions about their diabetes care and medication costs," he said.
Amazon has worked to lure customers away from more established pharmacies like CVS and Walgreens since launching its healthcare business in late 2020, announcing this month that it has doubled its active pharmacy users over the past year.
"Customers have got a lot of choices out there, and they're going to choose what's best for them, so we're going to create options that give them access to these medications," Amazon Pharmacy Vice President John Love told Reuters.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Aug 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Aug 23
